Fadi Brimo

44.6k total citations
146 papers, 3.3k citations indexed

About

Fadi Brimo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Fadi Brimo has authored 146 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 71 papers in Surgery and 37 papers in Molecular Biology. Recurrent topics in Fadi Brimo's work include Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (47 papers) and Prostate Cancer Treatment and Research (30 papers). Fadi Brimo is often cited by papers focused on Bladder and Urothelial Cancer Treatments (52 papers), Urinary and Genital Oncology Studies (47 papers) and Prostate Cancer Treatment and Research (30 papers). Fadi Brimo collaborates with scholars based in Canada, United States and France. Fadi Brimo's co-authors include Wassim Kassouf, Armen Aprikian, Jonathan I. Epstein, Simon Tanguay, Manon Auger, Faysal A. Yafi, Jordan Steinberg, José João Mansure, Charles C. Guo and Ming Zhou and has published in prestigious journals such as Nature Communications, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Fadi Brimo

140 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fadi Brimo Canada 33 1.5k 1.4k 946 803 467 146 3.3k
Robert Stoehr Germany 36 1.9k 1.3× 879 0.6× 1.5k 1.6× 1.1k 1.4× 576 1.2× 135 3.9k
Mercè Jordà United States 33 977 0.7× 1.3k 1.0× 855 0.9× 1.0k 1.3× 461 1.0× 157 3.2k
Masatsugu Iwamura Japan 27 795 0.5× 1.3k 1.0× 773 0.8× 822 1.0× 348 0.7× 204 2.9k
Jörg Hennenlotter Germany 36 1.1k 0.8× 1.3k 1.0× 1.8k 1.9× 1.0k 1.3× 827 1.8× 188 4.3k
James I. Geller United States 35 660 0.5× 1.8k 1.3× 2.5k 2.7× 792 1.0× 384 0.8× 163 4.0k
Gregor Mikuz Austria 29 948 0.7× 1.1k 0.8× 628 0.7× 504 0.6× 296 0.6× 116 2.6k
Hermann Rogatsch Austria 32 624 0.4× 1.1k 0.8× 775 0.8× 573 0.7× 289 0.6× 80 2.6k
Achim Fleischmann Switzerland 30 1.7k 1.2× 1.4k 1.0× 592 0.6× 615 0.8× 239 0.5× 68 3.6k
Michael R. Pins United States 26 729 0.5× 801 0.6× 870 0.9× 660 0.8× 392 0.8× 68 2.3k
Ruta Gupta Australia 36 1.4k 1.0× 1.2k 0.9× 983 1.0× 1.6k 2.0× 500 1.1× 197 4.0k

Countries citing papers authored by Fadi Brimo

Since Specialization
Citations

This map shows the geographic impact of Fadi Brimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Brimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Brimo more than expected).

Fields of papers citing papers by Fadi Brimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi Brimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Brimo. The network helps show where Fadi Brimo may publish in the future.

Co-authorship network of co-authors of Fadi Brimo

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Brimo. A scholar is included among the top collaborators of Fadi Brimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Brimo. Fadi Brimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaud, Eva, José João Mansure, Mina Farag, et al.. (2025). The Clinical Relevance of Tertiary Lymphoid Structures in Assessing Treatment Response in Muscle-Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 124(3). 726–732.
2.
Hamel, Lucie, Rafael Sanchez‐Salas, Wassim Kassouf, et al.. (2025). Clinical significance of stratifying prostate cancer patients through specific circulating genes. Molecular Oncology. 19(5). 1310–1331.
3.
Wilde, Blake R., Fadi Brimo, Heather R. Christofk, et al.. (2024). Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic. Genes Chromosomes and Cancer. 63(2). e23221–e23221. 2 indexed citations
4.
5.
Masoomian, Mehdi, Kiril Trpkov, Michelle R. Downes, et al.. (2023). ABCC2 brush‐border expression predicts outcome in papillary renal cell carcinoma: a multi‐institutional study of 254 cases. Histopathology. 83(6). 949–958. 3 indexed citations
6.
Arseneault, Madeleine, et al.. (2022). A Sarcomatoid Renal Cell Carcinoma with Clear Cell Papillary-Like Primary Tumor and Lymph Node Metastasis: A Diagnostic Conundrum. International Journal of Surgical Pathology. 31(5). 890–895. 3 indexed citations
7.
Marcq, Gautier, José João Mansure, Luís Souhami, et al.. (2022). Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy. European Urology Open Science. 43. 14–21. 3 indexed citations
8.
Bhindi, Bimal, Girish S. Kulkarni, D. Robert Siemens, et al.. (2021). Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version. Canadian Urological Association Journal. 15(8). 230–9. 9 indexed citations
9.
Ebrahimizadeh, Walead, Karl‐Philippe Guérard, Eleonora Scarlata, et al.. (2020). Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification–Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples. Journal of Molecular Diagnostics. 22(10). 1246–1263. 5 indexed citations
10.
Piccirillo, Ciriaco A., et al.. (2019). PD-1/PD-L1 Immune Checkpoint Inhibition with Radiation in Bladder Cancer: In Situ and Abscopal Effects. Molecular Cancer Therapeutics. 19(1). 211–220. 39 indexed citations
11.
Shanks, Jonathan H., John R. Srigley, Fadi Brimo, et al.. (2019). Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 75(4). 453–467. 2 indexed citations
12.
Brimo, Fadi, Eleonora Scarlata, Lucie Hamel, et al.. (2019). Improving ultrasound-based prostate volume estimation. BMC Urology. 19(1). 68–68. 17 indexed citations
13.
Compérat, Éva, et al.. (2018). A practical guide to bladder cancer pathology. Nature Reviews Urology. 15(3). 143–154. 43 indexed citations
14.
Ponte, Rosalie, Franck P. Dupuy, Fadi Brimo, et al.. (2017). Characterization of myeloid cell populations in human testes collected after sex reassignment surgery. Journal of Reproductive Immunology. 125. 16–24. 17 indexed citations
15.
Al‐Qaoud, Talal, Fadi Brimo, Armen Aprikian, & Sero Andonian. (2015). BCG-Related Renal Granulomas Managed Conservatively. Canadian Urological Association Journal. 9(3-4). 200–200. 15 indexed citations
16.
Brimo, Fadi, Armen Aprikian, Mathieu Latour, et al.. (2013). Strategies for Biochemical and Pathologic Quality Assurance in a Large Multi-Institutional Biorepository; The Experience of the PROCURE Quebec Prostate Cancer Biobank. Biopreservation and Biobanking. 11(5). 285–290. 14 indexed citations
17.
Yafi, Faysal A., Fadi Brimo, Manon Auger, et al.. (2013). Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(1). 27.e1–27.e6. 70 indexed citations
18.
Violette, Philippe D., Samuel Abourbih, Konrad Szymañski, et al.. (2012). Solitary solid renal mass: can we predict malignancy?. British Journal of Urology. 110(11b). E548–52. 29 indexed citations
19.
Brimo, Fadi, et al.. (2010). Renal Epithelioid Angiomyolipoma With Atypia: A Series of 40 Cases With Emphasis on Clinicopathologic Prognostic Indicators of Malignancy. The American Journal of Surgical Pathology. 34(5). 715–722. 181 indexed citations
20.
Brimo, Fadi, et al.. (2009). Syndecan‐1 expression in prostate cancer and its value as biomarker for disease progression. British Journal of Urology. 106(3). 418–423. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Stoehr Breakdown of academic impact, for papers by Mercè Jordà Breakdown of academic impact, for papers by Masatsugu Iwamura Breakdown of academic impact, for papers by Jörg Hennenlotter Breakdown of academic impact, for papers by James I. Geller Breakdown of academic impact, for papers by Gregor Mikuz Breakdown of academic impact, for papers by Hermann Rogatsch Breakdown of academic impact, for papers by Achim Fleischmann Breakdown of academic impact, for papers by Michael R. Pins Breakdown of academic impact, for papers by Ruta Gupta
Rankless by CCL
2026